CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinoma.
Liu Y, Liang W, Chang Y, He Z, Wu M, Zheng H, Ke X, Lv M, Liu Q, Liu Q, Tang W, Huang Q, Lu Y, He M, Yang Q, Mo C, Wang J, Peng K, Min Z, Su H, Chen J.
Liu Y, et al. Among authors: min z.
Front Immunol. 2022 Sep 27;13:950884. doi: 10.3389/fimmu.2022.950884. eCollection 2022.
Front Immunol. 2022.
PMID: 36238304
Free PMC article.